Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - Docwire News
Doc Wire News,
Front Pharmacol. 2020 Nov 20;11:589146. doi: 10.3389/fphar.2020.589146. eCollection 2020.